These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Macrolide and ketolide resistance with Streptococcus pneumoniae. Doern GV. Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439 [Abstract] [Full Text] [Related]
5. Clinical impact of antibiotic resistance in respiratory tract infections. Klugman KP. Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654 [Abstract] [Full Text] [Related]
6. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Rothermel CD. Clin Infect Dis; 2004 May 15; 38 Suppl 4():S346-9. PubMed ID: 15127368 [Abstract] [Full Text] [Related]
7. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study. Zafar A, Hussain Z, Lomama E, Sibille S, Irfan S, Khan E. J Ayub Med Coll Abbottabad; 2008 May 15; 20(1):7-9. PubMed ID: 19024175 [Abstract] [Full Text] [Related]
8. [The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2001 and 2002]. Melo-Cristino J, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias. Rev Port Pneumol; 2003 May 15; 9(4):293-310. PubMed ID: 19771688 [Abstract] [Full Text] [Related]